Lung Cancer and Interstitial Lung Diseases
Cancers · 13.08.2024 · 16 (16) · 2837
DOI: 10.3390/cancers16162837 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.08.2024. Verfasst von Fotios Drakopanagiotakis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumonology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer continues to be one of the leading causes of cancer-related death worldwide. There is evidence of a complex interplay between lung cancer and interstitial lung disease (ILD), affecting disease progression, management strategies, and patient outcomes. Both conditions develop as the result of common risk factors such as smoking, environmental exposures, and genetic predispositions. The presence of ILD poses diagnostic and therapeutic challenges in lung cancer management, including difficulties in interpreting radiological findings and increased susceptibility to treatment-related toxicities, such as acute exacerbation of ILD after surgery and pneumonitis after radiation therapy and immunotherapy. Moreover, due to the lack of large, phase III randomized controlled trials, the evidence-based therapeutic options for patients with ILDs and lung cancer remain limited. Antifibrotic treatment may help prevent pulmonary toxicity due to lung cancer treatment, but its effect is still unclear. Emerging diagnostic modalities and biomarkers and optimizing personalized treatment strategies are essential to improve outcomes in this patient population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pneumonology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
- European IPF Registry & Biobank (eurIPFreg/Bank), 35394 Giessen, Germany.
- Center for Interstitial and Rare Lung Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35394 Giessen, Germany.
- Department of Pneumonology, General Anti-Cancer Oncological Hospital, Agios Savvas, 11522 Athens, Greece.
- Department of Thoracic and Cardiovascular Surgery, University Hospital Würzburg, 97070 Würzburg, Germany.
- Agaplesion Lung Clinic, 35753 Greifenstein, Germany.
ORCID-Profile: Fotios Drakopanagiotakis, Ekaterina Krauss, Ira Michailidou, Paschalis Steiropoulos
Zitieren
APA
Drakopanagiotakis, F., Krauss, E., Michailidou, I., Drosos, V., Anevlavis, S., Günther, A., & Steiropoulos, P. (2024). Lung Cancer and Interstitial Lung Diseases. Cancers, 16(16), 2837. https://doi.org/10.3390/cancers16162837
Vancouver
Drakopanagiotakis F, Krauss E, Michailidou I, Drosos V, Anevlavis S, Günther A, et al. Lung Cancer and Interstitial Lung Diseases. Cancers. 2024;16(16):2837. doi:10.3390/cancers16162837
BibTeX
@article{Drakopanagiotakis2024,
author = {Drakopanagiotakis, Fotios and Krauss, Ekaterina and Michailidou, Ira and Drosos, Vasileios and Anevlavis, Stavros and Günther, Andreas and Steiropoulos, Paschalis},
title = {Lung Cancer and Interstitial Lung Diseases},
journal = {Cancers},
year = {2024},
volume = {16},
number = {16},
pages = {2837},
doi = {10.3390/cancers16162837}
}
EUVIMED